NCT00819013View on ClinicalTrials.gov

Safety Study of Recombinant M2e Influenza-A Vaccine in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

February 28, 2009

Conditions
Influenza
Interventions
BIOLOGICAL

Influenza A Vaccine: ACAM FLU-A

0.5 mL ACAM-FLU-A low dose + Adjuvant 1, Intramuscular

BIOLOGICAL

Influenza A Vaccine: ACAM FLU-A

0.5 mL ACAM-FLU-A low dose + Adjuvant 2, Intramuscular

BIOLOGICAL

Influenza A Vaccine: ACAM FLU-A

0.5 mL ACAM FLU-A low dose, Intramuscular

BIOLOGICAL

Saline placebo

0.5 mL, Intramuscular

Trial Locations (3)

33143

Miami Research Associates, Miami

66219

Johnson County Clin-Trials, Lenexa

98418

Northwest Kinetics, Tacoma

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY